Jill M. Quigley is Director at Terns Pharmaceuticals, Inc. (TERN). They have made 1 open-market trade across 1 company since 2020, most recently 2025-11-04.
CIK 0001799780
1 open-market purchase totalling $45K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TERN | SELL · 10b5-1 | 2025-11-04 | 2025-11-05 | $18.00 | $441K | +43.5% | +64.9% | +116.3% |
| TERN | SELL · 10b5-1 | 2025-01-02 | 2025-01-06 | $5.77 | $137K | -22.4% | -18.4% | -65.0% |
| TERN | SELL · 10b5-1 | 2024-09-09 | 2024-09-11 | $10.00 | $172K | -10.3% | -29.3% | -36.2% |
| TERN | SELL · 10b5-1 | 2024-08-01 | 2024-08-05 | $7.55 | $180K | -17.0% | -9.5% | -12.3% |
| TERN | SELL · 10b5-1 | 2024-07-15 | 2024-07-17 | $10.00 | $148K | -12.8% | -24.1% | -20.4% |
| PASG | SELL · 10b5-1 | 2021-01-20 | 2021-01-22 | $30.01 | $39K | -2.3% | -6.4% | -16.3% |
| PASG | SELL · 10b5-1 | 2021-01-14 | 2021-01-15 | $30.10 | $491K | -31.0% | -24.2% | -40.3% |
| PASG | BUY | 2020-03-03 | 2020-03-03 | $18.00 | $45K | -23.6% | -25.3% | +7.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.